
Noviral is a company founded as a result of the outbreak of Covid-19 with the vision to help Swedish companies get their employees back to the workplace quickly and safely. The company is founded by entrepreneurs and has had a medical advisory board since its inception, which assists with counseling and expertise in immunology. Noviral offers a variety of high-quality tests for Covid-19 as well as digital solutions for infection and symptom monitoring. The company also supports research and Swedish authorities through data collection.
Advisory Board

Otto Stackelberg, MD, PhD
Mr Stackelberg is a vascular surgeon at Södersjukhuset, Stockholm, Sweden. Mr Stackelberg is currently working in the intensive care unit taking care of COVID-19 patients. PhD in epidemiology and biostatistics.

Sara Mangsbo
Mrs Mangsbo is a lecturer in Experimental Clinical Immunology and Assistant Lecturer in Protein Drugs at Uppsala University, Sweden. Mrs. Mangsbo is the Co-founder of Immuneed AB and Vivologica AB, and works as the Development Manager at Ultimovacs AB / ASA.